Edarbi
Edarbi tablets contain Azilsartan medoxomil, a medication specifically designed to manage hypertension. By blocking angiotensin II receptors, it helps relax blood vessels, facilitating smoother blood flow and reducing blood pressure. Edarbi is typically prescribed for patients who require consistent blood pressure control. Regular usage can help lower the risk of strokes and heart attacks associated with high blood pressure. It is generally taken once daily, providing a convenient dosing schedule. Patients are advised to monitor their blood pressure regularly to assess the medication's efficacy. As with most antihypertensive medications, maintaining a healthy lifestyle enhances its effectiveness.Active substance:
Azilsartan medoxomilPharmachologic effect:
Edarbi is an angiotensin II receptor blocker (ARB) that works by relaxing blood vessels, allowing blood to flow more easily, thereby lowering blood pressure.Indications:
- Hypertension (high blood pressure)
Contraindications:
- Hypersensitivity to azilsartan medoxomil or any of the excipients
- Severe hepatic impairment
- Biliary cirrhosis
- Cholestasis
- Pregnancy
Side effects:
In order of decreasing probability: Dizziness, Diarrhea, Increased blood creatine phosphokinase, Fatigue, Nausea
Dosing and Administration:
The recommended starting dose of Edarbi is 40 mg once daily. The dose may be increased to a maximum of 80 mg once daily if additional blood pressure reduction is required.
Storage:
Store at a temperature not exceeding 30°C (86°F).
Edarbi
in Cyrillic : Эдарби
SUBSTANCE
Azilsartan medoxomil
DOSAGE FORM
tablets
MANUFACTURER
In Stock
available pack options :
| 40mg x 28 tablets | $44.10 | |
| 20mg x 28 tablets | $38.60 |
